Is Windlas biotech IPO good?

Is Windlas biotech IPO good?

The initial public offer of Windlas Biotech received bids for 13.78 crore shares as against 61.36 lakh shares on offer, according to stock exchange data. The issue was subscribed 22.47 times. The qualified institutional buyers (QIBs) category was subscribed 24.40 times.

What is GMP of Windlas IPO?

Windlas Biotech grey market premium (GMP) were around ₹130. The grey market is an unofficial platform, wherein trading starts after the announcement of IPO price band till the listing of IPO shares. The company’s shares will be listed on NSE and BSE.

Is Windlas biotech profitable?

READ ALSO:   Which European military alliance are the US and Canada also?

The P&L A/C page of Windlas Biotech Ltd….Profit & Loss – Windlas Biotech Ltd. Rs (in Crores)

Mar’20 Mar’19
TOTAL EXPENDITURE 288.18 243.74
Operating Profit 40.67 44.47
EBITDA 41.63 46.59
Depreciation 8.69 8.09

How is Windlas biotech IPO?

Windlas Biotech’s ₹ 401.5 crore IPO comprised a fresh issue of ₹ 165 crore and an offer for sale worth ₹ 236.5 crore. Windlas Biotech shares opened for trading at ₹ 437. The leading pharmaceutical company sold shares in the price band of ₹ 448 to ₹ 460 per equity share.

Is Rolex Rings IPO allotment out?

The last date to register for Rolex Rings IPO was 30 July 2021. According to the reports, it is the this is the 5th most registered IPO of year 2021….Rolex Rings IPO Allotment.

Company Rolex Rings
Allotment Date 5th August 2021
GMP Price Rs 530-550 (Acc to IPO Watch)
Trading Starts from 9th August

Is Windlas biotech IPO oversubscribed?

Windlas Biotech IPO oversubscribed by 22.47 times, QIB portion booked 24.4 times on final day.

READ ALSO:   What is the difference between robbery and pickpocket?

Is Windlas biotech IPO allotted?

Windlas Biotech IPO allotment status is expected on Aug 11, 2021.

Who owns Windlas biotech?

Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass, and the Promoter Trust are the promoters of the company. Promoters and promoter group holds an aggregate of 14,201,352 equity shares, aggregating to 78\% of the pre-offer issued and paid-up equity share capital.

What does Cdmo stand for in pharma?

contract development and manufacturing company
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.

How do I get IPO allotment for sure?

8 Ways To Increase IPO Allotment Chances

  1. Avoid large applications.
  2. Apply with more than one demat account.
  3. Always bid at the cut-off price.
  4. Don’t rush at the last minute.
  5. Purchase parent company shares.
  6. Remember to approve the mandate request.
  7. Apply within the first two days.
  8. Verify all details carefully.
READ ALSO:   Does homeopathy cure hyperthyroidism?

What is the price of windwindlas biotech IPO?

Windlas Biotech IPO is a main-board IPO of [.] equity shares of the face value of ₹5 aggregating up to ₹401.54 Crores. The issue is priced at ₹448 to ₹460 per equity share.

Who is windlas Biotech Ltd?

Incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India.

How many times did krsnaa diagnostics IPO get subscribed after bidding?

After the end of bidding Krsnaa Diagnostics IPO has been subscribed 64.38 times, Devyani International IPO got subscribed huge 116.70 times, Windlas Biotech IPO got subscribed 22.44 times while Exxaro Tiles IPO received 22.65 times subscription.

When will the basis of allotment of IPO be finalized?

The basis of allotment will be finalized on 11 August. If you have applied for the IPO, you can check your allotment status online. You can either check your allotment status on the BSE website or the IPO registrar, Link Intime.